In socialised medicine, the ability to read costs and benefits is curtailed. The National Health Service has been allowed by the National Institute for Clinical Excellence to fund a pill that aids smokers to stop the habit.
Champix costs £1.95 per patient per day. Anti-smoking campaigners welcomed Nice's provisional ruling, saying the £163.80 cost to the NHS for each 12-week course would be more than recouped from the NHS's £1.5 billion annual bill for treating diseases caused by smoking.
Others questioned why people who chose to take up smoking should receive help from the public purse to give up when Nice has turned down funding for a number of Alzheimer's and cancer drugs.
However, this decision may save a certain number of lives. Yet, it represents another step towards state intervention in health on the grounds of cost. Other behaviours identified as costly or destructive to the National Health Service could be prohibited through law, bans and aid to wean people from their 'addiction'. With the new mood-altering pharmacopeia coming, this presents new possibilities for state health.
Yet, the NHS is unable to clean its hospitals or record deaths accurately.
Mr Shapps, MP for Welwyn Hatfield, said: "We now know that C. difficile infects eight times as many people as the far better-known MRSA (staphylococcus aureus) and it actually kills twice as many patients." The report cited disturbing figures that last year, C. difficile claimed the lives of 4,752 patients - a 25 per cent rise on the previous year and a 111 per cent increase since 2004. Overall, 11,000 people had died in the three years since 2004 "to some degree attributed to clostridium difficile", the report said. To reduce the figures, people under the age of 65 who contract this bug may be given an alternative cause of death. The reason why we cannot assess costs and benefits accurately is that a socialised health service is a politicised health service.